Skin Longevity Series

The Lens of Evidence Concentration — The Line Between "Contains" and "Works"

KAIAN R&D Team | Published: 2026-07-14

When a label says a product "contains" a trendy ingredient, we tend to read it as "it works." But an ingredient's effect is decided not by whether it is present, but by how much is present. As the foundation of this series, we begin with the single most important piece of literacy — the idea of evidence concentration.

Evidence concentration is the level at which an ingredient's effect was actually demonstrated in clinical research. Studies showed an effect because they tested a specific concentration; far below that level, there is no guarantee the same effect appears.

Evidence Concentration: A Quick Reference by Ingredient Typical concentrations at which effects were shown in studies (varies by formula, pH, vehicle) 1% 5% 10% 20% Retinol 0.1–1% Salicylic Acid (BHA) 0.5–2% Dipotassium Glycyrrhizate 0.1–0.3% Niacinamide 2–5% Tranexamic Acid 2–5% Peptide (Matrixyl) 3–8% (active) Azelaic Acid 10–20% Vitamin C (Ascorbic Acid) 10–20% Arbutin 2–7% Concentration over "contains." Below the studied level, the proven effect may not hold. * Higher is not always better (irritation, plateau). pH, formulation, and delivery also change real-world efficacy. KAIAN / EVIDENCE CONCENTRATION

1. "Contains" and "works" are different words

Many ingredients have an "effective range" confirmed in research. Niacinamide is reported to act on brightening and barrier function at 2–5%; ascorbic acid (vitamin C) has been discussed for antioxidant and collagen-signaling effects at a relatively high 10–20%. Retinol works at 0.1–1%, azelaic acid at 15–20% as a medicine — the amount needed to work differs greatly by ingredient.

Yet the market is full of products that add a buzzy ingredient in only a trace amount — just enough to print its name on the list. In English this is called "fairy dusting." The name is genuinely there, but it falls far short of the concentration at which an effect was shown. This is not a lie, but it is not honest either.

"Being present" and "being present at a working dose" are entirely different things. When we say "choose by evidence," evidence concentration sits at the very center of that evidence.

2. Why low-concentration products exist

There are three main reasons. First, cost: active ingredients are often expensive, and raising the concentration raises the price. Second, marketing: "formulated with the latest ingredient" can be written regardless of dose. Third, formulation limits: some ingredients cause irritation or instability at higher levels, so they are deliberately kept low.

Low concentration is not always bad. The problem is presenting something as effective when its concentration does not meet the conditions under which the effect was shown. This is hard for consumers to spot — which is exactly why reading skill matters.

3. How to estimate concentration from the ingredient list

The full ingredient list offers one clue: as a rule, ingredients are listed in descending order of amount (though those at 1% or less may be listed in any order, so the latter half does not reflect concentration). If your target ingredient sits right after base ingredients like water and glycerin, it is likely highly dosed; far down the list, likely a trace.

  • Near the top (close to water, sodium hyaluronate, glycerin): the ingredient may be a leading player.
  • Middle: around 1%. Ingredients that work in small amounts, like retinol or salicylic acid, can be effective even here.
  • Far down, after the preservative: possibly an "impression" dose that does not reach evidence concentration.

Note that position alone is not conclusive. Some ingredients work at 0.1–0.3%, like dipotassium glycyrrhizate, and some are discussed as actives, like peptides. The right approach is not "low = meaningless," but "read the position knowing that ingredient's effective concentration."

4. Higher is not necessarily better

Knowing evidence concentration, it is tempting to think "the higher the better" — but this too is wrong. Many ingredients plateau, and beyond that point only the downsides grow: irritation and barrier strain. High-concentration vitamin C that stings, or retinol that causes redness, are classic examples.

Moreover, concentration is not the only thing that decides real-world efficacy. pH, formulation, delivery design, and ingredient combinations all matter. The same concentration performs differently depending on whether it actually reaches the skin. So we reject the simplistic view that "higher concentration wins." The studied concentration, within the limits of irritation and stability, in a form that reaches the skin — that is the essence of design.

5. KAIAN's stance, and the promise of this series

In our ingredient dictionary, KAIAN openly discloses each ingredient's recommended concentration, mechanism, and the strength of its evidence. The philosophy of Skin Longevity — extending the functional lifespan of skin — is not realized by listing trendy ingredient names. Only by designing effective concentrations in a form you can keep using can we support skin's function over time.

In every article you read here, we discuss ingredients together with their working concentration. By amount, not by name. By evidence, not by impression. That is the way of choosing that carries your skin into the next ten years.

Whenever you read about any ingredient, please ask: "Is it present at a working concentration?" That one question turns skincare from sensation into evidence.

References

Key peer-reviewed sources behind the scientific statements in this article.

  1. Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, Greatens A, Hillebrand GG, Bissett DL, Boissy RE. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20–31. PubMed
  2. Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol. 2000;143(3):524–531. PubMed
  3. Pinnell SR, Yang H, Omar M, Monteiro-Riviere N, DeBuys HV, Walker LC, Wang Y, Levine M. Topical L-ascorbic acid: percutaneous absorption studies. Dermatol Surg. 2001;27(2):137–142. PubMed
This article is reference information about cosmetic ingredients and does not guarantee efficacy. Figures and test results vary by condition.
← Back to Journal